Comparison of Efficacy of Intercessional Injection of Glucantime and Cryotherapy with Intralesional Injection in the Treatment of Zoonotic Cutaneous leishmaniasis:a Randomized Clinical Trial
DOI:
https://doi.org/10.22100/jkh.v8i2.26Keywords:
Cutaneous leshmaniasis, Glucantime, Cryothrapy, Intraregional injectionAbstract
Introduction: This study was done to compare the efficacy of interlesional injection of Glucantime method and cryotherapy with interlesional injection in treatment of cutaneous leishmaniasis in Qom province.
Methods: In this randomized controlled trial patients were randomly allocated in the two arms of the study:one receiving interalesional Glucantime injection weekly and the other receiving biweekly cryothrapy with intralesional injections of Glucantime. At first, the lesion size and induration of lesions were recorded after 7 and 12 weeks, and treatment of lesions was monitored. Healing was defined as complete re-epithelialisation and disappearance of induration.
Results: Out of a total of 197 CL patientsm 112 cases with L. major were studied. 54 cases with 116 lesions received intralesional Glucantime injection and 58 patients with 115 lesions received cryothrapy with intralesional injections of Glucantime. At 7th week after the initiation of the treatment, complete healing was observed in56 out of 116 lesions (48.1%) in the group which received weekly intralesional IG injection and 83 out of 115 lesions (72.2%) in the group which received biweekly GI with IG&cryothrapy. At 12th week after the initiation of the treatment, complete healing was observed in 105 out of 116 lesions (91%) in the group which received weekly intralesional IG injection and 115 out of 115 lesions (%100) in the group which received biweekly GI with IG & cryothrapy. By the end of 7th week, RR (0.95CI) amounted to 1.86(1.1 – 3.15) and at the end of 12th week they tapped to 3.4 (2.23- 2.27) which are statistically significant (P<0.02). The significant difference was observed between the two groups in terms of complete healing rate (P<0.05).
Conclusion: Based on the findings, cryothrapy with biweekly intralesional injections of Glucantime was more effective compared with weekly intercessional Glucantime injection and reduced the period of treatment.
References
Hotez PJ, Savioli L, Fenwick A. Neglected Tropical Diseases of the Middle East and North Africa:Review of Their Prevalence, Distribution, and Opportunities for Control. J Plos Neg Trop Dis 2010;6(2):1-8.
WHO. Working to overcome the global impact of neglected diseases. First WHO report on neglected tropical diseases. 2010;Geneva, Switzerland.
WHO. TDR Strategic Direction for Research:Leishmaniasis. Available at:www.who.int/tdr 2002;Geneva, Switzerland.
Islamic Republic of Iran Ministry of Heath &Medical Education. [Principles of disease prevention and surveillance]. Tehran:Center for disease control 2008:249-255.[Persian].
Zijstra EE, Siddig Ali M, El-Hassan AM. Kala-azar in diplaced people from Southern Sudan:epidemiological, clinical and therapeutic findings, Trans. R. Soc. Trop. Med. Hyg,85(1991) 365-369.
Ministry of Health and Medical Education (I.R.Iran) center for Disease Management. Principles of leishmaniasis prevention & surveillance. Tehran:2007:32-36.[Persian].
Herbert MG. Protozoal Diseases. London:Oxford University Press;1999:1-281.
Morsy TA, Abdel Rahman EG, Ahmed MM. Treatment of cutaneous leishmaniasis with Pentostam or cryosurgery. J Egypt Soc Parasitol. 1989;19(2):533-43.
Teixeira AC, Paes MG, Guerra Jde O, Prata A, Silva-Vergara ML. Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 2007;49(4):235-238.
Alavi S.M, AlaviL. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. J Gorgan Uni Med Sci 2008;10(4):1-5. [Persian].
Mostaghim M, Heiazi SH, Tolouei S, Asilian A, Sadeghian G, Shatalebi MA, et al. Study of therapeutic effect of Paromomycin Sulfate in combination with Gentamicin Sulfate film for treatment of cutaneous Leishmaniasis. Urmia Medical J 2002;13(2):136-144.[Persian].
Haftbaradaran H, Nilforoushzadeh MA, Jaffary F. The Efficacy of 5% Trichloroacetic Acid Cream in the Treatment of Cutaneous Leishmaniasis Lesions. J Knowlede & Health Uni Med Sci 2010;4(4):18-21.[Persian].
Al-Majali O, Routh HB, Abuloham O, Bhowmik KR, Muhsen M, Hebeheba H. A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. Int J Dermatol 1997;36(6):460-2.
Bassiouny A, El Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1982;107(4):467-74.
Leibovici V, Aram H. Cryotherapy in acute cutaneous leishmaniasis. Int J Dermatol 1986;25(7):473-5.
Alkhawajah AM, Larbi E, Al-Gindan Y, Abahussein A, Jain S. Treatment of cutaneous leishmaniasis with antimony:intramuscular versus intralesional administration. Ann Trop Med Parasitol 1997;91(8):899-905.
Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988;119(1):53-7.
Yazdanpanah MJ, Ebrahimirad M, Khazaeinejad S. Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis. J Gorgan Uni Med Sci. 2006;3(19):16-19.[Persian].
Salmanpour R, Handjani F, Nouhpisheh MK. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate(Glucantime) for the treatment of cutaneous leishmaniasis. J Dermatolog Treat 2001;12(3):159-162.[Persian].
Faghihi G, Tavakoli-kia R. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Clin Exp Dermatol 2003;28(1):6-13.[Persian].
Al-Gindan Y, Kubba R, Omer AH, el-Hassan AM. Cryosurgery in old world cutaneous leishmaniasis. Br J Dermatol 1988;118(6):851-4.
Bassiouny A, El Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1982;107(4):467-474.
Gurei MS, Tatli N, Ozbilge H, Erel O, Seyrek A, Kocyigit A, et al. Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 2000;30(1):169-76.
Asilian A, Momeni A, Faghihi G, Sadeghi V, Sadeghi M, Sadeghi H. A comparison between cryotherapy alone and combined with intralesional Glucantime injection in the treatment of papulonodular Leishmaniasis. J Dermatol 2002;6(2):30-33. [Persian].
Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis:retrospectives and advances for the 21st century. Clin Dermatol 1999;17(3):305-315.
Rassi Y, Saghafipour A, Abai MR, Oshaghi MA. Phlebotomus papatasi and meriones libycus as the vector and reservoir host of cutaneous leishmaniasis in Qomrood district, Qom province. Central Iran, Asian pacific Journal of Tropical Medicine.4:97-100.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
